# A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)

> **NCT00527904** · PHASE3 · COMPLETED · sponsor: **POZEN** · enrollment: 239 (actual)

## Conditions studied

- Gastric Ulcer

## Interventions

- **DRUG:** PN400 (VIMOVO)
- **DRUG:** PN 400 (VIMOVO)

## Key facts

- **NCT ID:** NCT00527904
- **Lead sponsor:** POZEN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 239 (ACTUAL)
- **Last updated:** 2010-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00527904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00527904, "A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00527904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*